Magalhães Gabriela de Alencar Pinto, Thomson Joshua J, Smoczer Cristine, Young Laura Ann, Matos Adaias O, Pacheco Rafael Rocha, Souza Maria Trevelin, Zanotto Edgar Dutra, Puppin Rontani Regina Maria
Department of Health Sciences and Pediatric Dentistry, Pediatric Division, Piracicaba Dental School, UNICAMP, State University of Campinas, Piracicaba 13414-903, Brazil.
Division of Integrated Biomedical Sciences, University of Detroit Mercy School of Dentistry, Detroit, MI 48208, USA.
J Funct Biomater. 2023 May 30;14(6):302. doi: 10.3390/jfb14060302.
This study investigated the influence of incorporating Biosilicate on the physico-mechanical and biological properties of glass ionomer cement (GIC). This bioactive glass ceramic (23.75% NaO, 23.75% CaO, 48.5% SiO, and 4% PO) was incorporated by weight (5%, 10%, or 15%) into commercially available GICs (Maxxion R and Fuji IX GP). Surface characterization was made by SEM ( = 3), EDS ( = 3), and FTIR ( = 1). The setting and working (S/W time) times ( = 3) and compressive strength (CS) were analyzed ( = 10) according to ISO 9917-1:2007. The ion release (n = 6) was determined and quantified by ICP OES and by UV-Vis for Ca, Na, Al, Si, P, and F. To verify cell cytotoxicity, stem cells from the apical papilla (SCAP) were exposed to eluates ( = 3, at a ratio of 1.8 cm/mL) and analyzed 24 h post-exposure. Antimicrobial activity against (ATCC 25175, NCTC 10449) was analyzed by direct contact for 2 h ( = 5). The data were submitted for normality and lognormality testing. One-way ANOVA and Tukey's test were applied for the working and setting time, compressive strength, and ion release data. Data from cytotoxicity and antimicrobial activity were submitted for Kruskal-Wallis' testing and Dunn's post hoc test (α = 0.05). Among all experimental groups, only those with 5% (wt) of Biosilicate showed better surface quality. Only M5% showed a comparable W/S time to the original material ( = 0.7254 and = 0.5912). CS was maintained for all Maxxion R groups ( > 0.0001) and declined for Fuji IX experimental groups ( < 0.0001). The Na, Si, P, and F ions released were significantly increased for all Maxxion R and Fuji IX groups ( < 0.0001). Cytotoxicity was increased only for Maxxion R with 5% and 10% of Biosilicate. A higher inhibition of growth was observed for Maxxion R with 5% of Biosilicate (less than 100 CFU/mL), followed by Maxxion R with 10% of Biosilicate ( = 0.0053) and Maxxion R without the glass ceramic ( = 0.0093). Maxxion R and Fuji IX presented different behaviors regarding Biosilicate incorporation. The impacts on physico-mechanical and biological properties were different depending on the GIC, but therapeutic ion release was increased for both materials.
本研究调查了添加生物硅酸盐对玻璃离子水门汀(GIC)物理机械性能和生物学性能的影响。将这种生物活性玻璃陶瓷(23.75% NaO、23.75% CaO、48.5% SiO和4% PO)按重量(5%、10%或15%)添加到市售的GIC(Maxxion R和Fuji IX GP)中。通过扫描电子显微镜(SEM,n = 3)、能谱仪(EDS,n = 3)和傅里叶变换红外光谱仪(FTIR,n = 1)进行表面表征。根据ISO 9917-1:2007分析凝固时间和工作时间(S/W时间,n = 3)以及抗压强度(CS,n = 10)。通过电感耦合等离子体发射光谱法(ICP OES)以及紫外可见分光光度法测定和量化钙、钠、铝、硅、磷和氟的离子释放量(n = 6)。为验证细胞毒性,将根尖乳头干细胞(SCAP)暴露于洗脱液中(n = 3,比例为1.8 cm/mL),并在暴露24小时后进行分析。通过直接接触2小时分析对变形链球菌(ATCC 25175,NCTC 10449)的抗菌活性(n = 5)。将数据进行正态性和对数正态性检验。对工作时间、凝固时间、抗压强度和离子释放数据应用单因素方差分析和Tukey检验。细胞毒性和抗菌活性数据进行Kruskal-Wallis检验和Dunn事后检验(α = 0.05)。在所有实验组中,只有添加5%(重量)生物硅酸盐的组表现出更好的表面质量。只有M5%组的W/S时间与原始材料相当(p = 0.7254和p = 0.5912)。所有Maxxion R组的CS保持不变(p > 0.0001),而Fuji IX实验组的CS下降(p < 0.0001)。所有Maxxion R和Fuji IX组释放的钠、硅、磷和氟离子显著增加(p < 0.0001)。仅添加5%和10%生物硅酸盐的Maxxion R组细胞毒性增加。观察到添加5%生物硅酸盐的Maxxion R组对变形链球菌生长的抑制作用更高(低于100 CFU/mL),其次是添加10%生物硅酸盐的Maxxion R组(p = 0.0053)和未添加玻璃陶瓷的Maxxion R组(p = 0.0093)。Maxxion R和Fuji IX在添加生物硅酸盐方面表现出不同的行为。根据GIC的不同,对物理机械性能和生物学性能的影响也不同,但两种材料的治疗性离子释放均增加。